Cefotaxime
CEFOTAXIME FOR INJECTION, USP
Approved
Approval ID
ed23b6bc-32c7-4c50-a53d-313ae78e5623
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 25, 2021
Manufacturers
FDA
Hikma Pharmaceuticals USA Inc.
DUNS: 001230762
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cefotaxime
PRODUCT DETAILS
NDC Product Code0143-9930
Application NumberANDA065072
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMay 25, 2021
Generic NameCefotaxime
INGREDIENTS (1)
CEFOTAXIME SODIUMActive
Quantity: 500 mg in 1 1
Code: 258J72S7TZ
Classification: ACTIM
Cefotaxime
PRODUCT DETAILS
NDC Product Code0143-9931
Application NumberANDA065072
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMay 25, 2021
Generic NameCefotaxime
INGREDIENTS (1)
CEFOTAXIME SODIUMActive
Quantity: 1 g in 1 1
Code: 258J72S7TZ
Classification: ACTIM
Cefotaxime
PRODUCT DETAILS
NDC Product Code0143-9933
Application NumberANDA065072
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMay 25, 2021
Generic NameCefotaxime
INGREDIENTS (1)
CEFOTAXIME SODIUMActive
Quantity: 2 g in 1 1
Code: 258J72S7TZ
Classification: ACTIM